SUBSCRIBE: Print / eNewsletter
Benefits, Barriers, and Challenges to Using Proton Therapy for Cancer Treatment
This video reviews the benefits of proton therapy and some of the barriers and challenges preventing the integration of the technology into regular practice.
ASTRO 2017: Perineural Invasion in Head and Neck Cancer
This video highlights an education session on the challenge of perineural invasion in head and neck cancer from the 2017 ASTRO Annual Meeting.
Genetic Variants Could Predict Cancer's Resistance to Radiation Therapy
This video highlights a large-scale profiling effort that seeks to identify and classify mutant alleles driving resistance to radiation therapy across different cancer types.
RT for Breast Cancer Patients Is 'Less Scary' Than Anticipated
This video examines patient fears and misconceptions regarding radiation therapy for the treatment of breast cancer.
Role for Proton Therapy in Locally Advanced Non–Small-Cell Lung Cancer?
This video reviews results of a randomized trial comparing intensity modulated radiation therapy vs passively scattered proton therapy for locally advanced non–small-cell lung cancer.
Older HPV-Positive Oropharyngeal Cancer Patients Have High Treatment Tolerability
This video examines results of a study that looked at treatment tolerability in elderly patients with HPV-positive oropharyngeal squamous cell carcinoma.
Proton Therapy in Hodgkin Lymphoma Yields Favorable Acute Toxicity Profile
A new study found that Hodgkin lymphoma patients treated with consolidative proton therapy after chemotherapy had “excellent” early relapse-free survival rates and no early grade 3 radiation-related toxicities.
POINT: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate Cancer
Serial PSA testing with early salvage radiotherapy is a viable option in most high-risk men.
COUNTERPOINT: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate Cancer
The data for adjuvant radiotherapy remain strong.
Aggressive Treatment De-Escalation Feasible in HPV-Positive Oropharyngeal Cancer?
This video highlights 2-year results of a phase II study evaluating aggressive adjuvant chemoradiation dose de-escalation in HPV-positive oropharynx squamous cell carcinoma.